 |
PDBsum entry 4c0t
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Acs Chem Biol
8:2283-2292
(2013)
|
|
PubMed id:
|
|
|
|
|
| |
|
PIF-pocket as a target for C. albicans Pkh selective inhibitors.
|
|
D.Pastor-Flores,
J.O.Schulze,
A.Bahí,
R.Giacometti,
J.Ferrer-Dalmau,
S.Passeron,
M.Engel,
E.Süss,
A.Casamayor,
R.M.Biondi.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The phosphoinositide-dependent protein kinase 1, PDK1, is a master kinase that
phosphorylates the activation loop of up to 23 AGC kinases. S. cerevisiae has
three PDK1 orthologues, Pkh1-3, which also phosphorylate AGC kinases (e.g., Ypk,
Tpk, Pkc1, and Sch9). Pkh1 and 2 are redundant proteins involved in multiple
essential cellular functions, including endocytosis and cell wall integrity.
Based on similarities with the budding yeast, the Pkh of fungal infectious
species was postulated as a novel target for antifungals. Here, we found that
depletion of Pkh eventually induces oxidative stress and DNA double-strand
breaks, leading to programmed cell death. This finding supports Pkh as an
antifungal target since pharmacological inhibition of Pkh would lead to the
death of yeast cells, the ultimate goal of antifungals. It was therefore of
interest to further investigate the possibility to develop Pkh inhibitors with
selectivity for Candida Pkh that would not inhibit the human ortholog. Here, we
describe C. albicans Pkh2 biochemically, structurally and by using chemical
probes in comparison to human PDK1. We found that a regulatory site on the C.
albicans Pkh2 catalytic domain, the PIF-pocket, diverges from human PDK1.
Indeed, we identified and characterized PS77, a new small allosteric inhibitor
directed to the PIF-pocket, which has increased selectivity for C. albicans
Pkh2. Together, our results describe novel features of the biology of Pkh and
chemical biology approaches that support the validation of Pkh as a drug target
for selective antifungals.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |